Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Mitochondrial Diseases

3,4-dihydroxyphenylacetic acid has been researched along with Mitochondrial Diseases in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, XF1
Wang, W1
Wang, DQ1
Zhao, DZ1
Du, GY1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Mitochondrial Diseases

ArticleYear
[Effects of Tianzhi Keli on extracellular acetylcholine and catecholamine levels in striatum of rats with neuromitochondrial impairment].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2005, Volume: 30, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Catecholamines; Corpus Striatum; Dopamine; D

2005